| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.022 | 0.7 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.7 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.02 | 0.7 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.7 |